CAR T-cell therapies have demonstrated efficacy in treating blood cancers but, so far, their safety and effectiveness in ...

CAR T-cell therapy for cancer leads to similar safety and cancer outcomes in patients with and without preexisting autoimmune ...

Researchers have identified a method to enhance the effectiveness of a promising cancer treatment. They found that modifying ...

A research team has made a major discovery on how the CUL5 gene affects CAR-T cell therapy, an advanced cancer therapy. The study reveals that reducing the activity of the CUL5 gene helps CAR-T cells ...

More than 13 years after its initial FDA approval, Pfizer’s blood cancer drug Adcetris has nabbed another regulatory green ...

Interviews revealed what patients and their caregivers focus on and needed support throughout the CAR-T therapy trajectory.

CAR-T cell therapy is an advanced cancer treatment in which the patient's own immune cells (T cells) are genetically modified in a laboratory. A "chimeric antigen receptor" (CAR) is given to these ...

With another trial win, Bristol Myers Squibb is touting Breyanzi as the CD19-directed CAR-T therapy with positive readouts in the most cancer types. | With another trial win, Bristol Myers Squibb is ...

The FIRCE-1 trial investigating the CAR T-cell therapy firi-cel in relapsed/refractory large B-cell lymphoma has been ...

The BC Cancer Foundation is launching a fundraising campaign to support the next three years of immunotherapy research at BC ...